124924-36-3 Usage
Uses
Used in Pharmaceutical Industry:
(3-METHYL-4-NITRO-BENZOYLAMINO)-ACETIC ACID is used as an intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs and improve existing ones.
Used in Dye Industry:
(3-METHYL-4-NITRO-BENZOYLAMINO)-ACETIC ACID is used as a building block in the production of dyes, where its unique chemical structure can contribute to the creation of novel colorants.
Used in Organic Synthesis:
(3-METHYL-4-NITRO-BENZOYLAMINO)-ACETIC ACID is used as a versatile intermediate in organic synthesis, enabling the production of a wide range of organic compounds for various applications.
Used in Medicinal Research:
(3-METHYL-4-NITRO-BENZOYLAMINO)-ACETIC ACID is used as a potential candidate for medicinal purposes due to its biological activity, which can be explored for the development of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 124924-36-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,9,2 and 4 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 124924-36:
(8*1)+(7*2)+(6*4)+(5*9)+(4*2)+(3*4)+(2*3)+(1*6)=123
123 % 10 = 3
So 124924-36-3 is a valid CAS Registry Number.
124924-36-3Relevant academic research and scientific papers
Technetium-99m labeled p-aminohippuric acid analogues: renal function agents.
Zhang,Bhargava,Chun,Blaufox,Chervu
, p. 829 - 832 (2007/10/02)
A number of p-aminohippuric acid analogues were synthesized in order to develop clinically useful 99mTc-labeled radiopharmaceuticals for evaluation of renal function measurements. Stable 99mTc-labeled complexes were formed at pH 5.7 using a Sn(II) reduction method with all derivatives. The newly synthesized complexes were screened utilizing biodistribution studies in small animals. All complexes were excreted via the GU tract within 60 min post iv administration, with no significant activity in GI tract and liver. The [99mTc]methyl-PAHIDA complex showed optimal biodistribution among these analogues. Further investigation is needed to determine if these derivatives may be used to replace [131I]o-iodohippuric acid for the evaluation of renal function.
